Abuse Resistance an Issue with Opioid Generics

(MedPage Today) -- As patents on popular opioid painkillers OxyContin (oxycodone) and Opana (oxymorphone) start expiring, makers of the brand products warn that the potential non-tamper-resistant generics are unsafe, and some legislators are concerned as well.
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news